Sarepta Therapeutics Inc (SRPT)

Current ratio

		Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
Total current assets	US$ in thousands	2,464,860	2,579,330	2,450,850	2,472,610	2,488,380	2,557,860	2,625,930	2,469,300	2,530,950	2,604,100	2,185,310	2,265,220	2,271,350	2,485,200	2,322,670	2,459,420	2,547,350	1,468,910	1,362,300	1,427,420
Total current liabilities	US$ in thousands	608,709	653,659	450,743	498,654	536,884	619,604	602,916	545,566	454,962	452,733	373,443	425,022	364,736	416,026	378,388	354,896	306,429	264,767	215,856	162,089
Current ratio		4.05	3.95	5.44	4.96	4.63	4.13	4.36	4.53	5.56	5.75	5.85	5.33	6.23	5.97	6.14	6.93	8.31	5.55	6.31	8.81

March 31, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $2,464,860K ÷ $608,709K
= 4.05

The current ratio of Sarepta Therapeutics Inc has displayed some fluctuations over the past few quarters, with a range from a low of 3.95 to a high of 8.81. The current ratio measures the company's ability to cover its short-term liabilities with its current assets. A higher current ratio indicates a better ability to meet short-term obligations.

In the most recent quarter (March 31, 2024), the current ratio stood at 4.05, which indicates that the company had $4.05 in current assets for every $1 in current liabilities. This ratio has been relatively consistent in the range of 4 to 5 over the past few quarters, suggesting that Sarepta Therapeutics Inc typically has a solid liquidity position.

Overall, while the current ratio has fluctuated, the company has maintained a healthy level of current assets relative to current liabilities, indicating a strong ability to meet its short-term financial obligations. As an analyst, it would be important to continue monitoring this metric to assess the company's liquidity position over time.